TickerFactsScreenerDevelopers

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2003: $1.42M2004: $11.23M2005: $28.03M2006: $31.61M2007: $26.46M2008: $12.30M2009: $4.86M2010: $8.08M2011: $12.56M2012: $8.81M2013: $25.73M2014: $165.99M2015: $109.62M2016: $95.02M2017: $80.87M2018: $95.24M2019: $244.04M2020: $461.78M2021: $408.82M2022: $418.34M2023: $287.16M2024: $191.06M2025: $503.42M$503.42M
2003Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$503.42M+163.5%
2024$191.06M-33.5%
2023$287.16M-31.4%
2022$418.34M+2.3%
2021$408.82M-11.5%
2020$461.78M+89.2%
2019$244.04M+156.2%
2018$95.24M+17.8%
2017$80.87M-14.9%
2016$95.02M-13.3%
2015$109.62M-34.0%
2014$165.99M+545.0%
2013$25.73M+192.1%
2012$8.81M-29.9%
2011$12.56M+55.5%
2010$8.08M+66.3%
2009$4.86M-60.5%
2008$12.30M-53.5%
2007$26.46M-16.3%
2006$31.61M+12.8%
2005$28.03M+149.6%
2004$11.23M+690.8%
2003$1.42M—